Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vladimir Tesar

Showing results (151-160 of 193) with videos related to

Pageof 20
Sort By:
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 21, 2018
Characteristics and Outcomes of Patients With Systemic Sclerosis (Scleroderma) Requiring Renal Replacement Therapy in Europe: Results From the ERA-EDTA RegistryZdenka Hruskova, Maria Pippias, Vianda S Stel, et al.
The New England Journal of Medicine|November 10, 2025
Sibeprenlimab in IgA Nephropathy - Interim Analysis of a Phase 3 TrialVlado Perkovic, Hernán Trimarchi, Vladimir Tesar, et al.
Annals of the Rheumatic Diseases|October 31, 2023
Data quality and patient characteristics in European ANCA-associated vasculitis registries: data retrieval by federated queryingKarl Gisslander, Matthew Rutherford, Louis Aslett, et al.
Nature Reviews. Nephrology|August 24, 2022
Impact of the COVID-19 pandemic on the kidney community: lessons learned and future directionsDuvuru Geetha, Andreas Kronbichler, Megan Rutter, et al.
Ebiomedicine|July 14, 2026
Individualised treatment effects of corticosteroids in IgA nephropathyDavid L Hölscher, Nikolas E J Schmitz, Leon Niggemeier, et al.
Nephron|November 21, 2015
Tonsillectomy in a European Cohort of 1,147 Patients with IgA NephropathyJohn Feehally, Rosanna Coppo, Stéphan Troyanov, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 8, 2022
An update on the use of tolvaptan for autosomal dominant polycystic kidney disease: consensus statement on behalf of the ERA Working Group on Inherited Kidney Disorders, the European Rare Kidney Disease Reference Network and Polycystic Kidney Disease InternationalRoman-Ulrich Müller, A Lianne Messchendorp, Henrik Birn, et al.
Annals of the Rheumatic Diseases|March 31, 2019
2019 update of the EULAR recommendations for the management of systemic lupus erythematosusAntonis Fanouriakis, Myrto Kostopoulou, Alessia Alunno, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 26, 2020
The switch from proteasome to immunoproteasome is increased in circulating cells of patients with fast progressive immunoglobulin A nephropathy and associated with defective CD46 expressionLicia Peruzzi, Rosanna Coppo, Enrico Cocchi, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 11, 2018
Defective gene expression of the membrane complement inhibitor CD46 in patients with progressive immunoglobulin A nephropathyRosanna Coppo, Licia Peruzzi, Elisa Loiacono, et al.
Pageof 20

Showing results (151-160 of 193) with videos related to

Sort By:
Pageof 20
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 21, 2018
Characteristics and Outcomes of Patients With Systemic Sclerosis (Scleroderma) Requiring Renal Replacement Therapy in Europe: Results From the ERA-EDTA RegistryZdenka Hruskova, Maria Pippias, Vianda S Stel, et al.
The New England Journal of Medicine|November 10, 2025
Sibeprenlimab in IgA Nephropathy - Interim Analysis of a Phase 3 TrialVlado Perkovic, Hernán Trimarchi, Vladimir Tesar, et al.
Annals of the Rheumatic Diseases|October 31, 2023
Data quality and patient characteristics in European ANCA-associated vasculitis registries: data retrieval by federated queryingKarl Gisslander, Matthew Rutherford, Louis Aslett, et al.
Nature Reviews. Nephrology|August 24, 2022
Impact of the COVID-19 pandemic on the kidney community: lessons learned and future directionsDuvuru Geetha, Andreas Kronbichler, Megan Rutter, et al.
Ebiomedicine|July 14, 2026
Individualised treatment effects of corticosteroids in IgA nephropathyDavid L Hölscher, Nikolas E J Schmitz, Leon Niggemeier, et al.
Nephron|November 21, 2015
Tonsillectomy in a European Cohort of 1,147 Patients with IgA NephropathyJohn Feehally, Rosanna Coppo, Stéphan Troyanov, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 8, 2022
An update on the use of tolvaptan for autosomal dominant polycystic kidney disease: consensus statement on behalf of the ERA Working Group on Inherited Kidney Disorders, the European Rare Kidney Disease Reference Network and Polycystic Kidney Disease InternationalRoman-Ulrich Müller, A Lianne Messchendorp, Henrik Birn, et al.
Annals of the Rheumatic Diseases|March 31, 2019
2019 update of the EULAR recommendations for the management of systemic lupus erythematosusAntonis Fanouriakis, Myrto Kostopoulou, Alessia Alunno, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 26, 2020
The switch from proteasome to immunoproteasome is increased in circulating cells of patients with fast progressive immunoglobulin A nephropathy and associated with defective CD46 expressionLicia Peruzzi, Rosanna Coppo, Enrico Cocchi, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 11, 2018
Defective gene expression of the membrane complement inhibitor CD46 in patients with progressive immunoglobulin A nephropathyRosanna Coppo, Licia Peruzzi, Elisa Loiacono, et al.
Pageof 20